Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pituitary function

Acromegaly: where are we now?

Nature Reviews Endocrinology volume 5, pages 420–422 (2009)Cite this article

A new consensus guideline offers an expert opinion for a multidisciplinary approach to acromegaly. How much headway have we made?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Melmed, S. et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94, 1509–1517 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. Melmed, S. et al. Guidelines for acromegaly management. J. Clin. Endocrinol. Metab. 87, 4054–4058 (2002).

    Article  CAS  PubMed  Google Scholar 

  3. Colao, A. et al. Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients. J. Clin. Endocrinol. Metab. 91, 2112–2118 (2006).

    Article  CAS  PubMed  Google Scholar 

  4. Katznelson, L. Drug insight: primary medical therapy of acromegaly. Nat. Clin. Pract. Endocrinol. Metab. 2, 109–117 (2006).

    Article  CAS  PubMed  Google Scholar 

  5. Feenstra, J. et al. Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly. Lancet 365, 1644–1646 (2005).

    Article  CAS  PubMed  Google Scholar 

  6. Carlsen, S. M. et al. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 93, 2984–2990 (2008).

    Article  CAS  PubMed  Google Scholar 

  7. Arafat, A. M. et al. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J. Clin. Endocrinol. Metab. 93, 1254–1262 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanford University School of Medicine, Stanford, CA, USA

    Laurence Katznelson

Authors
  1. Laurence Katznelson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurence Katznelson.

Ethics declarations

Competing interests

The author declares associations with the following companies: Ambrilia (consultant), Ipsen (speaker's bureau), Novartis (consultant, grant/research support).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Katznelson, L. Acromegaly: where are we now?. Nat Rev Endocrinol 5, 420–422 (2009). https://doi.org/10.1038/nrendo.2009.143

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.143

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing